AI & ChatGPT searches , social queries for URELUMAB
Search references for URELUMAB. Phrases containing URELUMAB
See searches and references containing URELUMAB!
Search references for URELUMAB. Phrases containing URELUMAB
See searches and references containing URELUMAB!URELUMAB
Monoclonal antibody
Urelumab (BMS-663513 or anti-4-1BB antibody) is a fully human, non‐ligand binding, CD137 agonist immunoglobulin‐γ 4 (IgG4) monoclonal antibody. It was
Urelumab
Monoclonal antibody
Varlilumab Immune activation: Ipilimumab Durvalumab Nivolumab Tremelimumab Urelumab Other: Bertilimumab Ontamalimab Zanolimumab Combination: Nivolumab/relatlimab
Theralizumab
Immune system messenger protein which induces inflammation
Ruplizumab Tabalumab Tavolixizumab Teneliximab Tigatuzumab Toralizumab Urelumab Utomilumab Varlilumab Vorsetuzumab Vorsetuzumab mafodotin Decoy receptors:
Tumor_necrosis_factor
Protein found in humans
Currently, Utomilumab is the only mAb targeting CD137 on the market. Urelumab trials were temporarily halted due to risk of liver toxicity. Utomilumab
TNFRSF9
Ruplizumab Tabalumab Tavolixizumab Teneliximab Tigatuzumab Toralizumab Urelumab Utomilumab Varlilumab Vorsetuzumab Vorsetuzumab mafodotin Decoy receptors:
Lymphotoxin_beta_receptor
leukemia Ulocuplumab mab human CXCR4 (CD184) hematologic malignancies Urelumab mab human 4-1BB (CD137) cancer etc. Urtoxazumab mab humanized Escherichia
List of therapeutic monoclonal antibodies
List_of_therapeutic_monoclonal_antibodies
Experiment TNFα inhibitor
Ruplizumab Tabalumab Tavolixizumab Teneliximab Tigatuzumab Toralizumab Urelumab Utomilumab Varlilumab Vorsetuzumab Vorsetuzumab mafodotin Decoy receptors:
Pegipanermin
and Induced by Lymphocyte Activation (ILA). Targeted by Bristol Myers' Urelumab, a CD137 agonist antibody, in early trials with anti-PDL1 (CD274) mAbs;
List of human clusters of differentiation
List_of_human_clusters_of_differentiation
Protein superfamily of cytokine receptors
Ruplizumab Tabalumab Tavolixizumab Teneliximab Tigatuzumab Toralizumab Urelumab Utomilumab Varlilumab Vorsetuzumab Vorsetuzumab mafodotin Decoy receptors:
TNF_receptor_superfamily
InterPro Family
Ruplizumab Tabalumab Tavolixizumab Teneliximab Tigatuzumab Toralizumab Urelumab Utomilumab Varlilumab Vorsetuzumab Vorsetuzumab mafodotin Decoy receptors:
Lymphotoxin
Protein found in humans
Ruplizumab Tabalumab Tavolixizumab Teneliximab Tigatuzumab Toralizumab Urelumab Utomilumab Varlilumab Vorsetuzumab Vorsetuzumab mafodotin Decoy receptors:
Lymphotoxin_alpha
Protein-coding gene in the species Homo sapiens
Ruplizumab Tabalumab Tavolixizumab Teneliximab Tigatuzumab Toralizumab Urelumab Utomilumab Varlilumab Vorsetuzumab Vorsetuzumab mafodotin Decoy receptors:
Lymphotoxin_beta
Membrane receptor protein found in humans
Ruplizumab Tabalumab Tavolixizumab Teneliximab Tigatuzumab Toralizumab Urelumab Utomilumab Varlilumab Vorsetuzumab Vorsetuzumab mafodotin Decoy receptors:
Tumor necrosis factor receptor 2
Tumor_necrosis_factor_receptor_2
Protein superfamily
Ruplizumab Tabalumab Tavolixizumab Teneliximab Tigatuzumab Toralizumab Urelumab Utomilumab Varlilumab Vorsetuzumab Vorsetuzumab mafodotin Decoy receptors:
Tumor necrosis factor superfamily
Tumor_necrosis_factor_superfamily
Membrane receptor protein found in humans
Ruplizumab Tabalumab Tavolixizumab Teneliximab Tigatuzumab Toralizumab Urelumab Utomilumab Varlilumab Vorsetuzumab Vorsetuzumab mafodotin Decoy receptors:
Tumor necrosis factor receptor 1
Tumor_necrosis_factor_receptor_1
Monoclonal antibody
Varlilumab Immune activation: Ipilimumab Durvalumab Nivolumab Tremelimumab Urelumab Other: Bertilimumab Ontamalimab Zanolimumab Combination: Nivolumab/relatlimab
Spartalizumab
Urasal Ureaphil Urecholine uredepa (INN) uredofos (INN) urefibrate (INN) urelumab (USAN) Uremol Urese Urex Uri-Tet uridine triacetate (INN) Urisec Urised
List_of_drugs:_U
URELUMAB
URELUMAB
URELUMAB
URELUMAB
URELUMAB
URELUMAB
URELUMAB
URELUMAB
URELUMAB